Reuters: Regulatory News: FDA approves Novartis brain tumor drug for children

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

FDA approves Novartis brain tumor drug for children Aug 29th 2012, 20:40 Wed Aug 29, 2012 4:40pm EDT Aug 29 (Reuters) - U.S. health regulators approved Swiss drugmaker Novartis AG's drug Afinitor Disperz for the treatment of a rare brain tumor in children of age one year and above. The U.S. Food and Drug Administration said the drug is recommended to treat patients with tuberous sclerosis complex, a rare genetic disease that causes tumors to grow in the brain and other vital organs. Novartis's drug Afinitor is approved to treat patients with four other types of cancer.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions